Rabeprazole: Clinical Trials

54 trials of Rabeprazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 19 unknown, 3 recruiting, 1 not yet recruiting. 54 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 454Completed 29, Unknown 19, Recruiting 3, Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Rabeprazole: new trials by email Literature Review of Rabeprazole trials Research Report on Rabeprazole

Trials (filtered) newest first · largest first

All 54 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention
Zastaprazan, Rabeprazole - Chronic Coronary Syndrome
Phase 4RecruitingYonsei University1002026-04-022026-04-24
Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment
Keverprazan 10 days, Keverprazan 14 days, Rabeprazole - Helicobacter Pylori
Phase 4RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine4142024-02-192025-08-14
Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding
Proton Pump Inhibitors, No Proton Pump Inhibitors - Upper Gastrointestinal Hemorrhage
Phase 4Not yet recruitingWest China Hospital6722023-10-012023-09-28
Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
Rabeprazole, Colloidal Bismuth Pectin Granules, Amoxicillin - Helicobacter Pylori Infection
Phase 4UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine8552023-03-012023-05-15
Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection
Vonoprazan, Rabeprazole, Amoxicillin - Helicobacter Pylori Infection
Phase 4UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine3932022-08-012023-02-16
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
susceptibility-guided tailored therapy (Group A), guidelines-recommended empiric therapy (Group B) - Helicobacter Pylori Infection
Phase 4RecruitingNational Taiwan University Hospital4502022-04-112026-04-15
Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication
Berberine, Vonoprazan, Amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis
Phase 4CompletedXijing Hospital of Digestive Diseases3002021-12-012023-01-31
Helicobacter Pylori Eradication and Follow-up
Rabeprazole, Bismuth potassium citrate, Metronidazole - Helicobacter Pylori Infection
Phase 4UnknownShanghai Zhongshan Hospital44472021-09-302021-09-30
Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients
Rabeprazole, Bismuth potassium citrate, Metronidazole - Helicobacter Pylori Infection
Phase 4UnknownShanghai Zhongshan Hospital5042021-08-262021-09-14
Tetracycline Versus Doxycycline for HP Rescue Therapy
Rabeprazole, Bismuth potassium citrate, Metronidazole - Helicobacter Pylori Infection
Phase 4UnknownShanghai Zhongshan Hospital2422021-08-242021-08-26
PPI-amoxicillin for H. Pylori Treatment
Rabeprazole, Bismuth potassium citrate, Metronidazole - Helicobacter Pylori Infection
Phase 4UnknownShanghai Zhongshan Hospital7322021-08-202021-08-23
14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy
Vonoprazan and Amoxicillin, Vonoprazan, Amoxicillin and Clarithromycin, Rabeprazole, Amoxicillin, Clarithromycin and Metronidazole - Helicobacter Pylori Eradication
Phase 4UnknownKaohsiung Medical University9062021-08-062022-01-14
Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy
Berberine, Amoxicillin, Rabeprazole - Dyspepsia, Chronic Gastritis
Phase 4CompletedXijing Hospital of Digestive Diseases5242021-01-072023-01-31
Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment
Rabeprazole, Bismuth potassium citrate, Metronidazole - Helicobacter Pylori Infection
Phase 4UnknownShanghai Zhongshan Hospital2702020-12-202020-12-22
A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers
RABEprazole 20 Mg Oral Delayed Release Tablet, APO-Dabigatran 150mg - Atrial Fibrillation, Venous Thromboembolism
Phase 4CompletedPopulation Health Research Institute462020-01-032022-03-21
Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii
Saccharomyces boulardii, Placebo - Helicobacter Pylori Infection
Phase 4UnknownClinical Centre of Serbia2002019-06-012019-06-25
Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication
High-dose dual therapy (rabeprazole, amoxicillin), Bismuth High-dose dual therapy (rabeprazole, amoxicillin, tripotassium dicitrate bismuthate), Amoxicillin-Metronidazole Bismuth quadruple therapy - Helicobacter Pylori Infection
Phase 4CompletedNational Taiwan University Hospital6032019-05-302025-04-23
A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis
Omeprazole 20mg, Esomeprazole 20mg, Rabeprazole Sodium 20mg - Helicobacter Pylori Infection
Phase 4UnknownChangi General Hospital2522019-04-162020-10-08
Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days) - Helicobacter Pylori Infection
Phase 4UnknownShandong University602019-04-012019-03-08
A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
esomeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days), rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days) - Helicobacter Pylori Infection
Phase 4UnknownShandong University1202018-12-152018-12-04

Showing 20 of 54. Sign in to see all of them.

Conditions studied

Gastroesophageal Reflux (11)  ·  Esophagitis, Peptic (3)  ·  Gastrointestinal Hemorrhage (3)  ·  Heartburn (3)  ·  Gastrointestinal Diseases (2)  ·  Helicobacter Infections (2)  ·  Stomach Neoplasms (2)  ·  Stomach Ulcer (2)  ·  Adenocarcinoma (1)  ·  Atrial Fibrillation (1)  ·  Bacterial Infections (1)  ·  Duodenal Ulcer (1)  ·  Dyspepsia (1)  ·  Gastritis (1)  ·  Liver Cirrhosis (1)

Sponsors

National Taiwan University Hospital (7)  ·  Shanghai Zhongshan Hospital (5)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (3)  ·  The Catholic University of Korea (3)  ·  Xijing Hospital of Digestive Diseases (3)  ·  GlaxoSmithKline (2)  ·  Janssen Cilag Pharmaceutica S.A.C.I., Greece (2)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (2)  ·  Neutec Ar-Ge San ve Tic A.Ş (2)  ·  Shandong University (2)  ·  American University of Beirut Medical Center (1)  ·  Beijing Children's Hospital (1)  ·  Buddhist Tzu Chi General Hospital (1)  ·  Changi General Hospital (1)  ·  Chong Kun Dang Pharmaceutical (1)

Countries

China (14)  ·  Taiwan (11)  ·  South Korea (6)  ·  United States (5)  ·  Egypt (2)  ·  Turkey (Türkiye) (2)  ·  Australia (1)  ·  Burma (1)  ·  Canada (1)  ·  Indonesia (1)  ·  Japan (1)  ·  Lebanon (1)  ·  Singapore (1)

Top investigators

Taotao Liu, MD (5)  ·  Jyh-Chin Yang, M.D.Ph.D. (4)  ·  Ala' I Sharara, MD (1)  ·  ChangSeok Bang, MD, PhD (1)  ·  Chien-Yu Lu, MD (1)  ·  Daphne Shih Wen Ang, MD (1)  ·  Fu-Tien Chiang, MD, Phd (1)  ·  Hiun-Suk Chae, Professor (1)  ·  I-Chen Wu, MD, PhD (1)  ·  John Eikelboom, MBBS, MSc (1)

Results publications

PMID 19210493, PMID 20132153, PMID 21317257, PMID 25574111, PMID 30167954, PMID 34397042, PMID 37479526, PMID 37885233, PMID 39924352, PMID 40007457, PMID 40560185